Be able to discuss non-pharmacological therapy with a patient with GORD or Peptic Ulcer Disease
Level
This learning outcome is a primary level outcome.
Sessions
This learning outcome is taught in the following sessions:
-
Gastroenterology and Cancer (MET3A) (Year 3)
- SDL & CE: Gastro-Oesophageal Reflux Disease (GORD) [Priority 1]
Assessment
This learning outcome is assessed in the following ways:
- NOT YET CATEGORISED
